Real-time enrollment status for this urothelial carcinoma clinical trial
Current Status
Recruiting
Checked: August 27, 2026 at 7:21 PM UTC
| NCT Number | NCT05562830 |
| Recruiting Status | Recruiting |
| Condition | Urothelial Carcinoma |
| Phase | PHASE1 |
| Target Enrollment | 48 participants |
| Active Locations | 10 sites in the US |
| Sponsor | Merck Sharp & Dohme LLC |
| Last Updated on CT.gov | May 27, 2026 (May 27, 2026) |
As of August 27, 2026: Clinical trial NCT05562830 is currently recruiting participants. This phase1 study for urothelial carcinoma is actively seeking new participants at 10 locations across the United States. The study is sponsored by Merck Sharp & Dohme LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05562830 is actively recruiting participants as of August 27, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 10 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05562830 was last updated May 27, 2026 (May 27, 2026). HelloStudys verifies this status automatically.